PUMA BIOTECHNOLOGY, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 13th, 2022 • Puma Biotechnology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 13th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (“Agreement”) is made as of December 9, 2022 (the “Agreement Date”), by and among Puma Biotechnology, Inc., a Delaware corporation (the “Company”), and Alan H. Auerbach (the “Purchaser”).